Other functions: securx: preventing prescription drug diversion. N44DA-12-5572, to KDH research and communications, INC. Base award. 09/24/2012-09/23/2014.

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201200032C
Awardee
Awarding agency
Obligated
$749,970

Award facts

Contract value 100% obligated
$749,970.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30308, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 4 $0
Other Administrative Action 3 · Securx: preventing prescription drug diversion. POP: 09/24/2012-12/31/2014. N44DA-12-5560: administrative modification to change COR from marsha lopez, PH.d. To… $0
Other Administrative Action 2 $0
Other Administrative Action 1 · Phase II sbir contract, securx: preventing prescription drug diversion. N44DA-12-5572, to KDH research and communications, INC. 09/24/2012-09/23/2014. $0
Original award $749,970

Quick answers

Who was awarded contract HHSN271201200032C?

HHSN271201200032C was awarded to KDH Research And Communication, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2012.

How much is contract HHSN271201200032C worth?

The government has obligated $749,970 on HHSN271201200032C.

Was contract HHSN271201200032C competed?

The extent of competition for HHSN271201200032C was not available for competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award